Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
Authors
Keywords
-
Journal
Clinical & Developmental Immunology
Volume 2012, Issue -, Pages 1-28
Publisher
Hindawi Limited
Online
2012-05-11
DOI
10.1155/2012/753407
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of Antitumor Immune Response by Homeostatic Proliferation and CD28 Signaling
- (2014) T. Suzuki et al. JOURNAL OF IMMUNOLOGY
- Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells
- (2011) Eirini Katodritou et al. AMERICAN JOURNAL OF HEMATOLOGY
- Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class I
- (2011) Xiaosong Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Monoclonal antibodies in the treatment of multiple myeloma
- (2011) Paul G. Richardson et al. BRITISH JOURNAL OF HAEMATOLOGY
- The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
- (2011) Klaus Podar et al. BRITISH JOURNAL OF HAEMATOLOGY
- miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
- (2011) Lijuan Chen et al. CANCER LETTERS
- The kinase NIK as a therapeutic target in multiple myeloma
- (2011) Sandra Gardam et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy
- (2011) M. van Duin et al. HAEMATOLOGICA
- Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
- (2011) Kerry S. Campbell et al. IMMUNOLOGY
- Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway
- (2011) Masahiro Kizaki INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy
- (2011) Maurizio Chiriva-Internati et al. JOURNAL OF IMMUNOTHERAPY
- Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
- (2011) S Lamorte et al. LEUKEMIA
- Induction of myeloma-specific cytotoxic T lymphocytes responses by natural killer cells stimulated-dendritic cells in patients with multiple myeloma
- (2011) Thanh-Nhan Nguyen-Pham et al. LEUKEMIA RESEARCH
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is Secretion of Tumour-specific Antigen Important for Cancer Eradication by CD4+ T Cells? - Implications for Cancer Immunotherapy by Adoptive T Cell Transfer
- (2011) A. Corthay et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells
- (2010) Deok-Hwan Yang et al. ANNALS OF HEMATOLOGY
- Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies
- (2010) H. M. Horton et al. BLOOD
- Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
- (2010) A. P. Rapoport et al. BLOOD
- Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma
- (2010) Jaroslav Michalek et al. BRITISH JOURNAL OF HAEMATOLOGY
- CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?
- (2010) Cindy Lee et al. BRITISH JOURNAL OF HAEMATOLOGY
- Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma
- (2010) Avichai Shimoni et al. CANCER
- Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma
- (2010) Caroline Pabst et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Humoral immunotherapy of multiple myeloma: perspectives and perplexities
- (2010) Andrea Di Bernardo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
- (2010) J. Greiner et al. HAEMATOLOGICA
- Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab
- (2010) M. S. van der Veer et al. HAEMATOLOGICA
- Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
- (2010) M. de Weers et al. JOURNAL OF IMMUNOLOGY
- Antibody-maytansinoid conjugates for the treatment of myeloma
- (2010) Robert J. Lutz et al. mAbs
- Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies
- (2010) D. Ocadlikova et al. NEOPLASMA
- An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma
- (2009) Ravi Vij et al. AMERICAN JOURNAL OF HEMATOLOGY
- Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens
- (2009) Sang-Ki Kim et al. ANNALS OF HEMATOLOGY
- CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells
- (2009) Y.-T. Tai et al. BLOOD
- Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity
- (2009) S. Wilde et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- CD4+CD25+FoxP3+regulatory T cells are increased whilst CD3+CD4−CD8−αβTCR+Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden
- (2009) Sylvia Feyler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Novel Immunotherapies
- (2009) Qing Yi CANCER JOURNAL
- Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma
- (2009) D. Atanackovic et al. CLINICAL CANCER RESEARCH
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
- (2009) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)
- (2009) C. Tripodo et al. CURRENT CANCER DRUG TARGETS
- Potent antibody drug conjugates for cancer therapy
- (2009) Peter D Senter CURRENT OPINION IN CHEMICAL BIOLOGY
- Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma
- (2009) Nicolaus Kröger et al. EXPERIMENTAL HEMATOLOGY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease
- (2009) Katia Todoerti et al. EXPERIMENTAL HEMATOLOGY
- Emerging therapies for multiple myeloma
- (2009) Klaus Podar et al. EXPERT OPINION ON EMERGING DRUGS
- Natural killer cells - new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation
- (2009) S. Patil et al. INTERNAL MEDICINE JOURNAL
- Increased Plasma-Immune Cytokines throughout the High-Dose Melphalan-Induced Lymphodepletion in Patients with Multiple Myeloma: A Window for Adoptive Immunotherapy
- (2009) M. Condomines et al. JOURNAL OF IMMUNOLOGY
- In vitroactivation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells
- (2009) Fedor Kryukov et al. Journal of Immunotoxicology
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
- Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
- (2009) M Garayoa et al. LEUKEMIA
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
- (2009) H Quach et al. LEUKEMIA
- Targeted therapies in multiple myeloma
- (2009) Efstathios Kastritis et al. Targeted Oncology
- Cellular immunotherapy for multiple myeloma
- (2008) Jacalyn Rosenblatt et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study
- (2008) Luis F. Porrata et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Role of decorin in the antimyeloma effects of osteoblasts
- (2008) X. Li et al. BLOOD
- Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
- (2008) E. Alici et al. BLOOD
- Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors
- (2008) Irene Mo et al. BMC CELL BIOLOGY
- Anti-CD20 monoclonal antibody therapy in multiple myeloma
- (2008) Prashant Kapoor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study
- (2008) Hilmi Ege et al. BRITISH JOURNAL OF HAEMATOLOGY
- Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
- (2008) Jumei Shi et al. BRITISH JOURNAL OF HAEMATOLOGY
- CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
- (2008) E. D. Hsi et al. CLINICAL CANCER RESEARCH
- Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy
- (2008) W. Song et al. CLINICAL CANCER RESEARCH
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
- (2008) R. Berger et al. CLINICAL CANCER RESEARCH
- Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma
- (2008) Sebastian Belle et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma
- (2008) Maurizio Chiriva-Internati et al. Journal of Translational Medicine
- New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
- (2008) Enrique M Ocio et al. LANCET ONCOLOGY
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma
- (2008) Deok-Hwan Yang et al. LEUKEMIA RESEARCH
- Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
- (2008) Y. Onishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Radioimmunotherapy-Based Conditioning Regimens for Stem Cell Transplantation
- (2008) Michelle M. Zhang et al. SEMINARS IN HEMATOLOGY
- Toll-like Receptor–Mediated Signaling in Human Adipose-Derived Stem Cells: Implications for Immunogenicity and Immunosuppressive Potential
- (2008) Eleuterio Lombardo et al. TISSUE ENGINEERING PART A
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
- Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu
- (2007) Y.-T. Tai et al. BLOOD
- Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma
- (2007) Ya-Wei Qiang et al. BONE
- Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling
- (2007) Francesco Liotta et al. STEM CELLS
- Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses
- (2007) Suzanne L. Tomchuck et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started